{{The trial, which took place in the US, involved injecting two sufferers with a dose of the measles vaccine 10 000 times stronger than that used for normal vaccination. }} <\/p>\n
One of the sufferers experienced a total remission with all of her tumours vanishing. <\/p>\n
The other experienced a remission but her cancer soon returned, indicating the treatment might not work for all sufferers.<\/p>\n
The mechanism underlying the cure involves the injected virus latching on to the cancerous cells, particularly those found in tumours. <\/p>\n
The virus then destroys these cells, causing the tumours to disappear. Myeloma, however, is not restricted to tumours as it infects the bone marrow as well. <\/p>\n
The measles treatment completely cleared the bone marrow of any cancerous cells, meaning the patient was essentially cancer-free.<\/p>\n
This came after the patient had exhausted every other treatment option available, including radiation and chemotherapy. <\/p>\n
Adding another kind of treatment to those currently available should increase the number of cases that can be successfully treated, boosting survival rates.<\/p>\n
Multiple Myeloma kills over 70 000 people a year worldwide with a 5-year survival rate of only around 45%, making it one of the deadlier forms of cancer in the world today.<\/p>\n
Treating cancer with other diseases has been trialled several times before, with mixed success. The problem lies in the fact that cancer is such a diverse illness. <\/p>\n
No single disease can be used to treat every cancer, meaning scientists have to spend time determining which disease is best suited to the targeted cancer. <\/p>\n
Because it led to complete remission, this is the most successful trial to date.<\/p>\n
Obviously, results from two patients do not constitute significant evidence, but it is a cause for optimism. <\/p>\n
The Mayo Clinic plans to build on this discovery with a large-scale trial that will be launched by the end of the year.<\/p>\n","protected":false},"excerpt":{"rendered":"
{{The trial, which took place in the US, involved injecting two sufferers with a dose of the measles vaccine 10 000 times stronger than that used for normal vaccination. }} One of the sufferers experienced a total remission with all of her tumours vanishing. The other experienced a remission but her cancer soon returned, indicating […]<\/p>\n","protected":false},"author":2,"featured_media":2000052229,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[75],"byline":[334],"hashtag":[],"class_list":["post-14486","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-homenews","byline-igihe-reporter"],"bylines":[{"id":334,"name":"IGIHE Reporter","slug":"igihe-reporter","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":null}],"contributors":[{"id":334,"name":"IGIHE Reporter","slug":"igihe-reporter","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":null}],"featured_image":{"id":2000052229,"url":"https:\/\/en-images.igihe.com\/IMG\/logo\/arton14486.jpg","alt":"","caption":"","mime_type":"image\/jpeg","width":0,"height":0,"sizes":{"thumbnail":{"url":"https:\/\/en-images.igihe.com\/IMG\/logo\/arton14486.jpg","width":1,"height":1},"medium":{"url":"https:\/\/en-images.igihe.com\/IMG\/logo\/arton14486.jpg","width":1,"height":1},"medium_large":{"url":"https:\/\/en-images.igihe.com\/IMG\/logo\/arton14486.jpg","width":1,"height":1},"large":{"url":"https:\/\/en-images.igihe.com\/IMG\/logo\/arton14486.jpg","width":1,"height":1},"full":{"url":"https:\/\/en-images.igihe.com\/IMG\/logo\/arton14486.jpg","width":0,"height":0}}},"_links":{"self":[{"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/posts\/14486","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/comments?post=14486"}],"version-history":[{"count":0,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/posts\/14486\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/media\/2000052229"}],"wp:attachment":[{"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/media?parent=14486"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/categories?post=14486"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/tags?post=14486"},{"taxonomy":"byline","embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/byline?post=14486"},{"taxonomy":"hashtag","embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/hashtag?post=14486"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}